Revalesio
Phase 2Revalesio is a clinical-stage pharmaceutical company focused on treating the bioenergetic failure that is the root cause of many conditions that impact human health. Our pioneering research targets the mitochondria ― the cellular engine ― addressing foundational metabolic imbalances. These imbalances drive both the acute damage to the brain and the cerebral vascular system post-stroke, […]
About
Revalesio is a clinical-stage pharmaceutical company focused on treating the bioenergetic failure that is the root cause of many conditions that impact human health. Our pioneering research targets the mitochondria ― the cellular engine ― addressing foundational metabolic imbalances. These imbalances drive both the acute damage to the brain and the cerebral vascular system post-stroke, […]
Funding History
3Total raised: $58M
Company Info
Contact
Sectors
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile